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Abstract
Background: Antimicrobial resistance is driven by multiple factors. Resolving the threat to human and animal
health presented by drug-resistant infections remains a societal challenge that demands close collaboration
between scientists and citizens. We compared current public views about key contributing factors to antimicrobial
resistance with those expressed by experts.
Methods: Overarching factors contributing to antimicrobial resistance were identified following a review of literature.
The factors were then described in plain language and attached to ballot boxes at a public engagement event
organised by a university. Responses to each factor were counted at the end of the event.
Results: Four hundred five responses were received from 3750 visitors (11 % response rate). Nearly half of
responses (192/405, 47 · 4 %) considered the misuse/overuse of antibiotics in humans as the main determinant of
antimicrobial resistance. The misuse of antibiotics in animal health obtained 16 · 3 % (66/405) responses. However,
the lack of quick tests to diagnose infections received 10/405 votes (2 · 47 %), and the lack of effective vaccines
received one vote (0 · 25 %).
Conclusions: The majority of responses ascribed the emergence of drug-resistant infections to the misuse of
antibiotics in human and animals. Suboptimal dosing, availability of diagnostics and environmental contamination
were considered less influential on the development of antimicrobial resistance. The growing recognition of broader
multifaceted drivers of drug resistance by experts is not yet echoed in the public mind.
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Background
Resolving the threat to human and animal health pre-
sented by antimicrobial resistance remains a challenge
for health care systems across the world [1]. Although
an intrinsic characteristic of micro-organisms, the preva-
lence of clinically relevant antimicrobial resistance
(AMR) has been accelerated by the inappropriate use of
antimicrobial agents, in turn driven by several factors.
Some of those key determinants include suboptimal
prescribing and inadequate public adherence to recom-
mended behaviours such as completion of prescribed
antibiotic courses [2].
Public behaviours around antimicrobials are shaped by
multiple and interlinked factors, including structural
components such as access to adequate medical services
and medications [3], narratives about the power of anti-
biotics [4] and social mechanisms. [5] Public perceptions
about AMR may also be influenced by the characteristics
of the information available [6]. Such information may
not be appropriately formatted for a large segment of
citizens [7]. Equally, the population may not have neces-
sary skills to make effective use of the information pro-
vided [8]. For such reasons, scientific and health policy
* Correspondence: e.castro-sanchez@imperial.ac.uk
1National Institute of Health Research Health Protection Research Unit in
Healthcare Associated Infection and Antimicrobial Resistance, Imperial
College London, Hammersmith Campus, London W12 0NN, UK
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Castro-Sánchez et al. BMC Infectious Diseases  (2016) 16:465 
DOI 10.1186/s12879-016-1810-x
messages that focus largely on clinical and epidemio-
logical consequences of inappropriate use of antibi-
otics may fail to engage the attention of the public.
Additionally, scientific evidence that is not closely
aligned with public perceptions is likely to risk foster-
ing and encouraging a collective cognitive dissonance
about the AMR threat [9].
However, there is increasing evidence of gaps in public
knowledge and understanding of messages provided by
healthcare workers and clinicians related to antimicro-
bials and AMR [10]. Further, there is still a paucity of
data regarding the explanatory models employed by
citizens to understand the development, evolution or
transfer of resistance.
Following a recent Delphi round with international ex-
perts on key determinants of the global burden of AMR
[11], we explored the opinions of members of the public
about the same topic to determine the concordance
between the two groups.
Methods
Factor identification and plain language translation
Nine overarching factors were identified as contributing
to the global rise in AMR following review of the na-
tional and international scientific literature (briefly,
PubMed and the Cochrane Database of Systematic
Reviews were searched to identify English language pri-
mary research papers, systematic reviews, and meta-
analyses (Jan 01 1990–Sep 31 2014) relating to (“factor”
OR “driver” OR “cause”) AND “antimicrobial resistance”)
[11]. Each of these nine factors was then translated into
plain language with the aid of three community represen-
tatives. These translations were then piloted on 47 mem-
bers of the public, and further refinements made to the
language used (Table 1).
Participant recruitment
The final plain language summaries were then attached to
ballot boxes and placed at a dedicated activity stall at the
annual public engagement event organised by Imperial
College London university in London, United Kingdom
(UK). The stall was manned by a researcher and public at-
tendees of all ages who approached the stall were invited
to place one token each in the ballot box in that they
felt represented the biggest single cause driving global
antimicrobial resistance. Tokens in each box were
then summed at the end of the festival and appor-
tioned to each factor.
Comparison with expert opinion
A previous exercise had been undertaken previously
with nine experts in antimicrobial resistance who prac-
tice in disparate fields, from molecular biology through
to translational antimicrobial resistance research, clinical
infection practice and veterinary medicine. This panel
undertook a two-round Delphi process to similarly rank
the perceived contribution of each factor as a cause of
global antimicrobial resistance and in addition also
ranked the contributory scientific evidence for each
factor, and the potential population affected [11]. The
results from the public poll related to the relative contri-
bution of factors towards AMR were compared and con-
trasted to these expert results to explore any divergence.
Role of the funding source
The research was funded by the National Institute for
Health Research Health Protection Research Unit (NIHR
HPRU) in Healthcare Associated Infection and Anti-
microbial Resistance at Imperial College London in part-
nership with Public Health England (PHE). However, the
study funders had no influence on how the data were
collected, analysed, interpreted or presented. The views
Table 1 Factors identified as driving global antimicrobial resistance
Factors Plain language translation
Human antimicrobial mis-/over-use Misuse and/or overuse of antibiotics in humans (e.g. not finishing a course
of antibiotics, taking antibiotics for viral, rather than bacterial, infections)
Animal antimicrobial mis-/over-use Misuse and/or overuse of antibiotics in animals (e.g. farming)
Environmental contamination (including sewage and heavy
metals)
Waste products from antibiotics entering the environment (through manufacture,
sewage and disposal)
Healthcare transmission Resistant bacteria being passed between people in hospital and other healthcare areas
Sub-optimal rapid diagnostics A lack of quick, accurate tests to diagnose infections
Sub-optimal preventative medicine/vaccination A lack of effective vaccines and poor uptake of existing ones
Sub-optimal dosing, including from substandard and falsified
medications
Incorrect dosing of antibiotics in humans (e.g. not adjusting dosage for body weight)
Travel Human travel from one area of the globe to another, spreading resistant bugs
Mass drug administration in human health Mass drug administration – i.e. the regular giving of antibiotics to a large group of
people (e.g. a whole state or country) to treat an infection, regardless of whether
individuals are ill or not
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expressed are those of the author(s) and not necessarily
those of the NHS, the NIHR, the Department of Health
or Public Health England.
Results
Around 15,000 members of the public attended the
event, of whom approximately 3750 visited the area con-
taining the survey, where 405 responses (11 % response
rate) were received (Table 2). Nearly half of responses
(192/405, 47 · 4 %) considered the misuse/overuse of an-
tibiotics in humans as the main determinant of anti-
microbial resistance. The misuse of antibiotics in animal
health obtained 16 · 3 % (66/405) responses, closely
followed by the mass administration of antibiotics to
large populations to treat endemic infections. On the
other hand, the lack of quick, accurate tests to diagnose
infections received 10/405 votes (2 · 47 %), and the lack
of effective vaccines, or the poor uptake of existing ones,
was given one vote (0 · 25 %).
In general, and with the exception of ‘the misuse of
antibiotics in humans, the public attributed less relative
importance to each factor than the experts (Fig. 1). The
greatest discrepancies in opinion were seen on the sig-
nificance of lack of diagnostics (considered to be a high
driver of AMR by the experts, but of moderate-low im-
portance for the public), and the prominence of subopti-
mal dosing, ranked within the high-moderate category
by the experts, but as moderate-low by the public.
Discussion
Our survey asked the public attending a science communi-
cation event to identify the main reason underlying anti-
microbial resistance in the world. Understanding the beliefs
and explanatory frameworks used by citizens to make sense
about the connections between antimicrobials, microorgan-
isms and hosts, as well as the phenomenon of antimicrobial
resistance, can facilitate the design and implementation of
public awareness campaigns and strengthen future behav-
iour change interventions.
Nearly 2/3 of responses ascribed the emergence of re-
sistance to the misuse or overuse of antibiotics in human
and animal health. In view of the widely reported preva-
lence of suboptimal antimicrobial prescribing in human
healthcare and its impact on AMR [12], and the evi-
dence suggesting that resistance is intimately associated
with antimicrobial use [13], such responses from the
public could be considered adequate. Of the two factors,
a much larger proportion of individuals considered
human health as chiefly responsible for antimicrobial
resistance, when compared with animal health. This
perspective is remarkable in light of the relative con-
sumption of antimicrobials in veterinary medicine and
food production, several orders of magnitude higher
than human health [14].
A final group of determinants including travel, sub-
optimal dosing, environmental contamination and sub-
optimal rapid diagnostics was considered by respondents
to have a lower influence on the development of AMR.
The crucial role of rapid diagnostics in AMR seemed
clearly undervalued by the attendees to our event. Mod-
ern transport routes have proven to be very efficient
adjunct mechanisms of pathogen transmission [15].
However, worldwide transfer of antimicrobial resistant
organisms does not seem to match the mobility of
humans across the globe [16]. Suboptimal dosing across
human and animal health remains a persistent challenge,
either from insufficient evidence about the optimal man-
agement for particular groups such as obese individuals
[17], or from substandard medications [18]. Finally, the
presence of antimicrobials and antimicrobial-resistant
organisms in human food and animal feed as well as the
environment and its impact on human and animal
health have received growing attention [19]. Our partici-
pants attributed to the mass drug administration of anti-
biotics for public health reasons a moderate role in the
growth of resistance. However, the evidence to support
such perception is more uncertain [20–22].
The adequate responses we obtained need to be ap-
praised within the UK context, where several awareness
campaigns and interventions including public education
have been conducted [23]. The effectiveness of such
campaigns appears to be conflicting [24–26]. The UK
Chief Medical Officer (CMO) has also generated consid-
erable attention to the topic of antimicrobial resistance,
developing public engagement materials and effectively
guiding the social debate about antimicrobials and resist-
ance in social media [27].
The limited public understanding of the scientific dis-
course related to antimicrobials may offer an explanation
for the uncertain public campaign impact reported [28].
Such narrow understanding may reflect, overall, a lack
Table 2 Responses by attendees to public engagement event
Factors n/N (%)
Human antimicrobial mis-/over-use 192/405 (47 · 4 %)
Animal antimicrobial mis-/over-use 66/405 (16 · 3 %)
Mass drug administration in human health 57/405 (14 · 07 %)
Healthcare transmission 36/405 (8 · 89 %)
Travel 17/405 (4 · 2 %)
Sub-optimal dosing, including from
substandard or falsified medications
15/405 (3 · 7 %)
Environmental contamination (including
sewage and heavy metals)
11/405 (2 · 72 %)
Sub-optimal rapid diagnostics 10/405 (2 · 47 %)
Sub-optimal preventative medicine/vaccination 1/405 (0 · 25 %)
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of scientific skills and health literacy in particular of the
population [29, 30]. Unless such deficits are taken into
account and remedied, it is likely that recent recommen-
dations directing healthcare workers to educate citizens
about antibiotics at the point of clinical care [31] will
have limited success.
Limitations
We conducted our investigation at a public engagement
science event aimed at the public organised by a central
London university. The ballot boxes were displayed
within an area devoted to antimicrobial resistance, so
the visitors may have been a self-selected sample of indi-
viduals interested in this field, possibly with increased
education and information about AMR and its determi-
nants or encouraged to look up information related to
antimicrobials in advance. The ballot boxes were not
masked so some respondents may have been persuaded to
opt for the option which already had the highest number
of votes. Equally, we cannot be sure that some responses
were not provided by human or animal healthcare workers,
scientists or researchers, therefore skewing the proportion
of answers for the selected options.
Our activity only allowed people to select the main con-
tributing factor to antimicrobial resistance in their opin-
ion, where in reality antimicrobial resistance is an intricate
and ‘wicked’ problem [32]. We did not include an option
acknowledging resistance as a natural and evolutionary
response of microorganisms to the pressure exercised by
antimicrobials, therefore being a phenomenon that could
be slowed but not completely stopped.
Due to the design of our activity, we did not have an
opportunity to explore social and demographic attributes
of those taking part in the survey, which would have
been valuable to enrich hypothesis about current ex-
planatory and decision making frameworks used by
members of the public. Our findings must therefore be
corroborated by surveys with larger samples. We were
not able to explore participants’ views about the drivers
of such overuse or misuse of antibiotics using qualitative
approaches. However, these aspects have been partially
described already [33].
Conclusions
In our study public opinion was largely in agreement with
expert opinion characterising human antimicrobial misuse
as the greatest contributing factor toward antimicrobial
resistance. However, to further progress the public under-
standing of additional drivers of drug-resistant infections,
clear messages will need to be conceptualised, developed
and appropriately disseminated, mindful of health literacy
issues. As seen with some disease outbreaks, messages
supported by facts alone may be insufficient to engage
with all population segments, and emotional or practical
components may prove more useful content to inform the
public and initiate wide ranging discussions on these other
issues. In doing so, not only publically funded research
streams may be better targeted [34] but also public per-
ception of AMR and its causes might be better informed.
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